TSX News -
Brompton Energy Split Corp. Announces Preferred Share Distribution Rate
TORONTO, Jan. 26, 2024 (GLOBE NEWSWIRE) — (TSX: ESP, ESP.PR.A) Brompton Energy Split Corp. (the “Fund”) announces that the distribution […]
TSX News -
The Energy Income Fund has closed the private placement, issuing 699,397 units
TORONTO, Jan. 26, 2024 (GLOBE NEWSWIRE) — Artemis Investment Management Limited (“Artemis”), the trustee and manager of Energy Income Fund […]
Commencement of Public Consultation in Greenland
TORONTO, ONTARIO, Jan. 26, 2024 (GLOBE NEWSWIRE) — (“Amaroq” or the “Company”) Commencement of Public Consultation in Greenland TORONTO, ONTARIO […]
Hubbell Incorporated Declares Regular Quarterly Dividend
Shelton, CT, Jan. 26, 2024 (GLOBE NEWSWIRE) — The Board of Directors of Hubbell Incorporated (NYSE:HUBB) today declared a regular quarterly dividend […]
Gray’s InvestigateTV and WANF Presented with 2024 duPont-Columbia Award
ATLANTA, Jan. 26, 2024 (GLOBE NEWSWIRE) — Columbia Journalism School announced the 15 winners of the 2024 duPont-Columbia Awards during […]
Haynes International, Inc. to Host First Quarter Fiscal Year 2024 Conference Call
Company to host conference call on February 9, 2024 at 9:00 AM EST KOKOMO, Ind., Jan. 26, 2024 (GLOBE NEWSWIRE) […]
HII to Hold Investor Day
NEWPORT NEWS, Va., Jan. 26, 2024 (GLOBE NEWSWIRE) — HII (NYSE: HII) will host its Investor Day on March 20, […]
TSX News -
2 Boralex Projects Totalling 365 MW Selected in Hydro-Québec Wind Power Call for Tenders
MONTREAL, Jan. 26, 2024 (GLOBE NEWSWIRE) — Boralex inc. (“Boralex” or the “Company”) (TSX: BLX) is pleased to announce that […]
Mesa Air Group Reports Fourth Quarter and Fiscal Full-Year 2023 Results
PHOENIX, Jan. 26, 2024 (GLOBE NEWSWIRE) — Mesa Air Group, Inc. (NASDAQ: MESA) (“Mesa” or the “Company”) today reported fourth quarter and […]
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
HANOVER, Md., Jan. 26, 2024 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical […]
